Lenalidomide (hydrochloride)

Hersteller MedChem Express
Kategorie Produkte / Inhibitors
Typ Inhibitors
Specific against other
Menge 100mg
ArtNr HY-A0003A-100mg
Eclass 6.1 30220300
Eclass 9.0 32160605
CC-5013 hydrochloride, CC5013 hydrochloride, CC 5013 hydrochloride
10 mM in DMSO
Biological Description
Lenalidomide hydrochloride is a potent inhibitor of TNF-alpha and has antiangiogenic effect.
IC50 & Target: TNF-alpha[1]
In Vitro: Lenalidomide is potent in stimulating T cell proliferation and IFN-gamma and IL-2 production. Lenalidomide has been shown to inhibit production of pro inflammatory cytokines TNF-alpha, IL-1, IL-6, IL-12 and elevate the production of anti-inflammatory cytokine IL-10 from human PBMCs. Lenalidomide downregulates the production of IL-6 directly and also by inhibiting multiple myeloma (MM) cells and bone marrow stromal cells (BMSC) interaction, which augments the apoptosis of myeloma cells[2]. Dose-dependent interaction with the CRBN-DDB1 complex is observed with Thalidomide, Lenalidomide and Pomalidomide, with IC50 values of ?30?uM, ?3?uM and ?3?uM, respectively, These reduced CRBN expression cells (U266-CRBN60 and U266-CRBN75) are less responsive than the parental cells to antiproliferative effects Lenalidomide across a dose-response range of 0.01 to 10?uM[3].
In Vivo: The toxicity of Lenalidomide doses up to 15, 22.5, and 45 mg/kg via IV, IP, and PO routes of administration. Limited by solubility in our PBS dosing vehicle, these maximum achievable Lenalidomide doses are well tolerated with the exception of one mouse death (of four total dosed) at the 15 mg/kg IV dose. Notably, no other toxicities are observed in the study at IV doses of 15 mg/kg (n=3) or 10 mg/kg (n=45) or at any other dose level through IV, IP, and PO routes[4].
Menge: 100mg
Lieferbar: In stock
Listenpreis: 166,79 €
Preis: 166,79 €

Angebot anfordern

Technische Fragen zu diesem Produkt?

Salesmanager: Arne Pelz

Email: sales@hoelzel.de